# Cancer Genetics, Inc. (CGIX)

Source: https://www.quantisnow.com/company/CGIX
Generated: 2026-11-08T19:55:25.828Z

- Ticker: CGIX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: n/a

## Latest CGIX news and filings

- 2021-04-02 01:48 UTC [SEC Form 4] [SEC Form 4: John R Fletcher was granted 8,676 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-john-r-fletcher-was-granted-8676-units-580261)
- 2021-04-02 01:46 UTC [SEC Form 4] [SEC Form 4 filed by Marcus Boehm](https://www.quantisnow.com/insight/sec-form-4-filed-by-marcus-boehm-580258)
- 2021-04-02 01:32 UTC [SEC Form 4] [SEC Form 4 filed by Joanna Horobin](https://www.quantisnow.com/insight/sec-form-4-filed-by-joanna-horobin-580242)
- 2021-04-02 01:30 UTC [SEC Form 4] [SEC Form 4 filed by Howard Mcleod](https://www.quantisnow.com/insight/sec-form-4-filed-by-howard-mcleod-580239)
- 2021-04-02 01:29 UTC [SEC Form 4] [SEC Form 4 filed by Yung-Ping Yeh](https://www.quantisnow.com/insight/sec-form-4-filed-by-yung-ping-yeh-580234)
- 2021-04-02 01:27 UTC [SEC Form 4] [SEC Form 4 filed by R. Paul Hansen](https://www.quantisnow.com/insight/sec-form-4-filed-by-r-paul-hansen-580231)
- 2021-04-02 01:27 UTC [SEC Form 4] [SEC Form 4 filed by E. Geoffrey Harris](https://www.quantisnow.com/insight/sec-form-4-filed-by-e-geoffrey-harris-580229)
- 2021-04-02 01:25 UTC [SEC Form 4] [SEC Form 4 filed by Ralf Brandt](https://www.quantisnow.com/insight/sec-form-4-filed-by-ralf-brandt-580226)
- 2021-04-02 01:24 UTC [SEC Form 4] [SEC Form 4 filed by D.C. Andrew Lafrence](https://www.quantisnow.com/insight/sec-form-4-filed-by-dc-andrew-lafrence-580225)
- 2021-04-02 01:21 UTC [SEC Form 4] [SEC Form 4 filed by A John Roberts](https://www.quantisnow.com/insight/sec-form-4-filed-by-a-john-roberts-580219)
- 2021-04-01 23:03 UTC [SEC Form 3 filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-cancer-genetics-inc-579965)
- 2021-04-01 23:01 UTC [SEC Form 3] [SEC Form 3 filed by Marcus Boehm](https://www.quantisnow.com/insight/sec-form-3-filed-by-marcus-boehm-579955)
- 2021-04-01 23:00 UTC [SEC Form 3] [SEC Form 3 filed by John R Fletcher](https://www.quantisnow.com/insight/sec-form-3-filed-by-john-r-fletcher-579950)
- 2021-04-01 22:59 UTC [SEC Form 3] [SEC Form 3 filed by Joanna Horobin](https://www.quantisnow.com/insight/sec-form-3-filed-by-joanna-horobin-579945)
- 2021-04-01 22:56 UTC [SEC Form 3] [SEC Form 3 filed by D.C. Andrew Lafrence](https://www.quantisnow.com/insight/sec-form-3-filed-by-dc-andrew-lafrence-579938)
- 2021-04-01 22:55 UTC [SEC Form 3] [SEC Form 3 filed by R. Paul Hansen](https://www.quantisnow.com/insight/sec-form-3-filed-by-r-paul-hansen-579933)
- 2021-03-31 10:30 UTC [Cancer Genetics and StemoniX Announce Merger Closing](https://www.quantisnow.com/insight/cancer-genetics-and-stemonix-announce-merger-closing-569864)
- 2021-03-31 10:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-cancer-genetics-inc-569766)
- 2021-03-25 13:17 UTC [SEC Form 8-K] [SEC Form 8-K filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cancer-genetics-inc-552595)
- 2021-03-25 13:15 UTC [Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX](https://www.quantisnow.com/insight/cancer-genetics-announces-shareholder-approval-of-all-proposals-in-connection-552593)
- 2021-03-25 13:15 UTC [SEC Form 425] [SEC Form 425 filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-cancer-genetics-inc-552579)
- 2021-03-18 12:30 UTC [Leadership Update] [Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development](https://www.quantisnow.com/insight/cancer-genetics-announces-roland-j-carrillo-phd-as-vice-president-526136)
- 2021-03-16 11:02 UTC [SEC Form 8-K] [SEC Form 8-K filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cancer-genetics-inc-514286)
- 2021-03-16 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Cancer Genetics, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-cancer-genetics-inc-514217)
- 2021-03-12 14:30 UTC [Conference Announcement] [Cancer Genetics to Present at the Annual 33rd ROTH Conference](https://www.quantisnow.com/insight/cancer-genetics-to-present-at-the-annual-33rd-roth-conference-505571)
- 2021-03-04 21:15 UTC [Conference Announcement] [Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference](https://www.quantisnow.com/insight/cancer-genetics-to-present-at-the-hc-wainwright-global-life-474582)
- 2021-02-26 21:42 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-447658)
- 2021-02-26 21:46 UTC [SEC Form DEFR14A filed](https://www.quantisnow.com/insight/sec-form-defr14a-filed-447642)
- 2021-02-26 21:40 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-447587)
- 2021-02-25 20:05 UTC [SEC Schedule 13D] [SEC Form SC 13D filed](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-441095)
- 2021-02-16 21:51 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-402883)
- 2021-02-16 21:45 UTC [Public Offering] [Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules](https://www.quantisnow.com/insight/cancer-genetics-announces-closing-of-175-million-common-stock-offering-402596)
- 2021-02-16 05:16 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-395704)
- 2021-02-11 02:43 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-380606)
- 2021-02-11 02:56 UTC [SEC Form 424B5 filed](https://www.quantisnow.com/insight/sec-form-424b5-filed-380537)
- 2021-02-11 02:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-380519)
- 2021-02-11 04:00 UTC [Public Offering] [Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules](https://www.quantisnow.com/insight/cancer-genetics-announces-175-million-common-stock-offering-priced-at-the-market-379997)
- 2021-02-09 11:17 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-366369)
- 2021-02-09 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-366275)
- 2021-02-08 22:22 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-365139)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CGIX
- Earnings history: https://www.quantisnow.com/earnings/CGIX
- Dividend history: https://www.quantisnow.com/dividends/CGIX
- Insider transactions: https://www.quantisnow.com/insiders/CGIX
- Options chain: https://www.quantisnow.com/options/CGIX
- SEC 8-K filings only: https://www.quantisnow.com/company/CGIX/8-k
- RSS and alerts for CGIX: https://www.quantisnow.com/docs/rss-feeds.md